Searchable abstracts of presentations at key conferences in endocrinology

ea0056ep146 | Reproductive Endocrinology | ECE2018

Endometrioid adenocarcinoma of abdominal wall in histerectomized patient 18 years before

Zambrano Monica , Buendia Richard , Campo Nicolas , Lopez Laura , Cruz Maria Alejandra Ramirez De La

A 69-year-old patient with a history of hysterectomy 18 years ago due to apparent uterine myomatosis, who presents with a clinical picture of 6 months of evolution of a solid suprapubic mass without any other associated symptomatology. Normal vaginal cytology 3 years ago; Menarche at 16 years of age and obstetric history: G1P2V2(Twin).Physical examination: Indurated mass in the suprapubic region, mobile, not painful External atrophic genitalia; Vaginal e...

ea0056p304 | Cardiovascular Endocrinology and Lipid Metabolism | ECE2018

Efficacy and safety of proprotein convertase subtilisin/kexintype nine inhibitors in real life experience

Navarro-Hoyas Clara , Moragrega Raquel Miralles , Delegido-Gomez Laura , Lopez-Munoz Beatriz , Moreno-Perez Oscar , Pico-Alfonso Antonio , Gonzalez-Sanchez Victor

Introduction: PCSK9 inhibitors (iPCSK9) have previously been evaluated through controlled clinical trials showing up to 60% reduction in LDL cholesterol concentrations. However, we still do not have enough data regarding the real life experience of the treatment.Objectives: 1) Describe patients with hypercholesterolemia treated with iPCSK9 in clinical practice.2) Evaluate treatment efficacy and safety.Methods...